Trial NCT04392128

View at ClinicalTrials.gov 
Org. Study IDs: 2020-005
Secondary IDs: 2020-002002-45

Last trial update was posted on 2020-09-04

MeSH Interventions

Azithromycin Hydroxychloroquine

MeSH Conditions

COVID-19 Hematologic Neoplasms Neoplasms

Other Conditions

COVID19 Hematologic Malignancy

Stopping Reasons

competent authority decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID